HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

New Landmark Study Published Online in Annals of Internal Medicine Show Bariatric Surgery Reduces or Eliminates Need for BP Medication in Obesity Patients in...

In the new three-year study, nearly three-quarters (73%) of gastric bypass patients were able to stop taking 30% or more of their antihypertensive medications and still maintain a blood pressure of less than 140/90 mm Hg, the study’s primary endpoint. Only 11% of those on standard medical therapy alone were able to do the same over the three-year follow-up period.

Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System

“SNM therapy is already proven to be safe and effective, but we expect the ELITE study to definitively reinforce established SNM evidence in patients implanted with the new InterStim Micro system,” said Victor Nitti, M.D., the Shlomo Raz Chair in urology, professor of urology and obstetrics and gynecology, and chief and fellowship director of Female Pelvic Medicine and Reconstructive Surgery at the David Geffen School of Medicine at UCLA.

Aroa Biosurgery Gains Further Validation for Endoform® According to a Published Study

Aroa BioSurgery lead scientist for the study, Dr. Sandi Dempsey, said the paper describes the ability of components found within the Endoform® ECM platform technology to signal stem cells in laboratory models.

Verndari Reports: Publication in the Journal Vaccine of Early Data Using VaxiPatch™ Vaccine System to Administer Flu Vaccine Reports

“The Verndari VaxiPatch™ system holds the promise of enabling faster development of vaccines for new threats such as COVID-19 as well as more effective vaccines for existing viruses, such as influenza,” said Dr. Daniel R. Henderson, CEO of Verndari.

NovaSignal’s Lucid Robotic System Used by Mount Sinai Health System Uncovers Possible Breakthrough in Patients with Covid-19: Published in the American Journal of Respiratory...

The Lucid Robotic System integrates cerebral ultrasound, robotics, and artificial intelligence and provides physicians with cerebral blood flow data which has proven to be critical for clinical decision making and improved patient outcomes.

Perspectum Partners with UT Southwestern Medical Center on Dallas Heart & Minds Study

The DHMS initial aim was to improve the diagnosis, prevention and treatment of heart disease, over the years this has expanded to encompass metabolic diseases, such as fatty liver disease.  

Nevisense to Be Included in a Large Clinical Study Initiated by The Ronald O. Perelman Department of Dermatology Clinic at NYU Langone Health

The SpotCheck study will investigate the use of Nevisense as a point-of-care diagnostic tool to assist with skin cancer detection in a remote setting such as a non-specialist practice or pharmacy.

FDA IDE Approval to Initiate a Pivotal Study of the NEXUS Aortic Arch Stent Graft System Has Been Announced

Earlier this year, FDA granted NEXUS™ Aortic Arch Stent Graft System as a breakthrough device.

First Patient Enrolled in PATHFINDER I Registry

The PATHFINDER I Registry is a pilot study to evaluate the safety and efficacy of the Auryon Atherectomy System in the real-world treatment of de novo, re-stenotic, and in-stent restenosis lesions in infrainguinal arteries of patients with Peripheral Artery Diseases.